---
title: "Innovation + Going Global, Highlights of Biopharmaceutical Companies' Q3 Reports"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263174632.md"
description: "As of October 28, over 280 listed pharmaceutical and biotechnology companies, including Hengrui Pharma, HUADONG MEDICINE, WuXi AppTec, and Sanyou Medical, have disclosed their Q3 2025 reports, with many companies presenting impressive \"report cards.\" Several pharmaceutical companies have achieved double growth in revenue and profit through the advancement of their R&D pipelines and the launch of innovative drugs, while breakthroughs in overseas business have injected new momentum into their performance. The industry as a whole is showing a positive development trend of \"innovation as the foundation and expanding overseas.\" (Shanghai Securities Journal)"
datetime: "2025-10-28T22:21:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263174632.md)
  - [en](https://longbridge.com/en/news/263174632.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263174632.md)
---

# Innovation + Going Global, Highlights of Biopharmaceutical Companies' Q3 Reports

As of October 28, over 280 listed pharmaceutical and biotechnology companies, including Hengrui Pharma, HUADONG MEDICINE, WuXi AppTec, and Sanyou Medical, have disclosed their Q3 2025 reports, with many companies delivering impressive "report cards." Several pharmaceutical companies have achieved double growth in revenue and profit through the advancement of their R&D pipelines and the launch of innovative drugs, while breakthroughs in overseas business have injected new momentum into their performance. The industry as a whole is showing a positive development trend of "innovation as the foundation and expanding overseas." (Shanghai Securities Journal)

### Related Stocks

- [603259.CN](https://longbridge.com/en/quote/603259.CN.md)
- [02359.HK](https://longbridge.com/en/quote/02359.HK.md)
- [688085.CN](https://longbridge.com/en/quote/688085.CN.md)
- [600276.CN](https://longbridge.com/en/quote/600276.CN.md)
- [000963.CN](https://longbridge.com/en/quote/000963.CN.md)

## Related News & Research

- [WuXi AppTec declares 2026 mid-year dividend of RMB 5.1 per 10 shares](https://longbridge.com/en/news/294669177.md)
- [Jiangsu Hengrui files HKEX next-day disclosure return reporting share repurchase at RMB 52.96](https://longbridge.com/en/news/294665198.md)
- [Metis TechBio to Deploy AI Formulation Platform at Hengrui Pharmaceuticals](https://longbridge.com/en/news/294641344.md)
- [FREDUN: Strong revenue and profit growth with robust compliance in the pharmaceutical segment](https://longbridge.com/en/news/294919739.md)
- [Real estate investment firm Appeninn weighs Warsaw listing, source says](https://longbridge.com/en/news/295089175.md)